Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114040273 | 11404027 | 3 | F | 20150312 | 20160719 | 20150821 | 20160726 | PER | PHHY2015US043223 | NOVARTIS | 40.88 | YR | F | Y | 0.00000 | 20160726 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114040273 | 11404027 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | QD | 22527 | CAPSULE | QD | ||||||||
| 114040273 | 11404027 | 2 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114040273 | 11404027 | 1 | Multiple sclerosis |
| 114040273 | 11404027 | 2 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114040273 | 11404027 | Alanine aminotransferase increased | |
| 114040273 | 11404027 | Headache | |
| 114040273 | 11404027 | Hypoaesthesia | |
| 114040273 | 11404027 | Influenza like illness | |
| 114040273 | 11404027 | Seasonal allergy | |
| 114040273 | 11404027 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114040273 | 11404027 | 2 | 20150421 | 20150630 | 0 |